Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Medicina Clinica
|
August 7, 2009
[The complement system as a main actor in the pathogenesis of obstetric antiphospholipid syndrome]
Jaume Alijotas-Reig
Obstetrical & Gynecological Survey
|
December 31, 2009
Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?
Jaume Alijotas-Reig, Miquel Vilardell-Tarres
Postgraduate Medical Journal
|
February 15, 2015
Recurrent miscarriage: causes, evaluation and management
Carmen Garrido-Gimenez, Jaume Alijotas-Reig
Obstetrical & Gynecological Survey
|
August 15, 2013
Current concepts and new trends in the diagnosis and management of recurrent miscarriage
Jaume Alijotas-Reig, Carmen Garrido-Gimenez
Medicina Clinica
|
November 17, 2005
[Recurrent miscarriage and inherited thrombophilia: diagnostic work-out and therapeutic management]
Jaume Alijotas-Reig, Juan Carlos Ferrer-Raventós
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
July 28, 2004
Life-threatening bleeding, pregnancy and lupus anticoagulant: success after steroid and anticoagulant therapy
Jaume Alijotas-Reig, Juan Carlos Ferrer-Raventos
Medicina Clinica
|
March 27, 2014
Regulatory T cells, maternal-foetal immune tolerance and recurrent miscarriage: new therapeutic challenging opportunities
Jaume Alijotas-Reig, Taisiia Melnychuk, Josep Maria Gris
Seminars in Arthritis and Rheumatism
|
May 7, 2013
Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers
Jaume Alijotas-Reig, Maria Teresa Fernández-Figueras, Lluís Puig
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 5, 2009
Circulating microparticles, lupus anticoagulant and recurrent miscarriages
Jaume Alijotas-Reig, Carles Palacio-Garcia, Miquel Vilardell-Tarres
Dermatology (Basel, Switzerland)
|
October 3, 2009
Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up
Jaume Alijotas-Reig, Victor Garcia-Gimenez, Miquel Vilardell-Tarres
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Medicina Clinica
|
August 7, 2009
[The complement system as a main actor in the pathogenesis of obstetric antiphospholipid syndrome]
Jaume Alijotas-Reig
Obstetrical & Gynecological Survey
|
December 31, 2009
Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?
Jaume Alijotas-Reig, Miquel Vilardell-Tarres
Postgraduate Medical Journal
|
February 15, 2015
Recurrent miscarriage: causes, evaluation and management
Carmen Garrido-Gimenez, Jaume Alijotas-Reig
Obstetrical & Gynecological Survey
|
August 15, 2013
Current concepts and new trends in the diagnosis and management of recurrent miscarriage
Jaume Alijotas-Reig, Carmen Garrido-Gimenez
Medicina Clinica
|
November 17, 2005
[Recurrent miscarriage and inherited thrombophilia: diagnostic work-out and therapeutic management]
Jaume Alijotas-Reig, Juan Carlos Ferrer-Raventós
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
July 28, 2004
Life-threatening bleeding, pregnancy and lupus anticoagulant: success after steroid and anticoagulant therapy
Jaume Alijotas-Reig, Juan Carlos Ferrer-Raventos
Medicina Clinica
|
March 27, 2014
Regulatory T cells, maternal-foetal immune tolerance and recurrent miscarriage: new therapeutic challenging opportunities
Jaume Alijotas-Reig, Taisiia Melnychuk, Josep Maria Gris
Seminars in Arthritis and Rheumatism
|
May 7, 2013
Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers
Jaume Alijotas-Reig, Maria Teresa Fernández-Figueras, Lluís Puig
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 5, 2009
Circulating microparticles, lupus anticoagulant and recurrent miscarriages
Jaume Alijotas-Reig, Carles Palacio-Garcia, Miquel Vilardell-Tarres
Dermatology (Basel, Switzerland)
|
October 3, 2009
Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up
Jaume Alijotas-Reig, Victor Garcia-Gimenez, Miquel Vilardell-Tarres
Page
of 9